Showing results (31-40 of 337) with videos related to

Sort By:
Pageof 34
Neoplasia (New York, N.Y.)|August 21, 2008
Co-opted JNK/SAPK signaling in Wnt/beta-catenin-induced tumorigenesisBo Liu, Hsiao-Man Ivy Yu, Jiaoti Huang, et al.
Precision Clinical Medicine|January 29, 2019
The promise of immunotherapy in genitourinary malignanciesTian Zhang, Andrew J Armstrong, Daniel J George, et al.
Case Reports in Psychiatry|November 12, 2020
Acuphagia on the Obsessive-Compulsive Spectrum in an Adolescent MaleWilliam Butler, Luis Allen
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostateJung Wook Park, John K Lee, Owen N Witte, et al.
Cancer Research|December 8, 2010
Invasive prostate carcinoma driven by c-Src and androgen receptor synergyHoujian Cai, Ivan Babic, Xiao Wei, et al.
The Journal of Pathology|February 8, 2023
Oncofetal protein glypican-3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancerWilliam Butler, Lingfan Xu, Yinglu Zhou, et al.
American Journal of Clinical Pathology|April 22, 2006
Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liverJun-Yi Lei, Patricia A Bourne, P Anthony diSant'Agnese, et al.
Biochemical and Biophysical Research Communications|December 31, 2002
Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machineryJing Ni, Ming Chen, Yu Zhang, et al.
The Prostate|January 20, 2015
Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytesElizabeth M Peek, Wang Song, Hanwei Zhang, et al.
Asian Journal of Urology|February 19, 2019
Targeting androgen receptor-independent pathways in therapy-resistant prostate cancerLingfan Xu, Junyi Chen, Weipeng Liu, et al.
Pageof 34